Flavin adenine dinucleotide
- Generic Name
- Flavin adenine dinucleotide
- Brand Names
- EnBrace HR, EnLyte
- Drug Type
- Small Molecule
- Chemical Formula
- C27H33N9O15P2
- CAS Number
- 146-14-5
- Unique Ingredient Identifier
- ZC44YTI8KK
- Background
A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)
Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
- Indication
Used to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
- Associated Conditions
- -
- Associated Therapies
- Folate supplementation therapy
Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2010-09-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT00840385
- Locations
- 🇨🇳
Cancer Hospital, Fudan University, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath